Eris Lifesciences has informed that the ‘Trading Window’ for dealing in the securities of the Company will be closed for all Designated Persons and their immediate relatives from 01 July 2022 and the same will remain closed till 48 hours after the announcement of Unaudited Financial Results for the quarter ending on 30 June 2022 to the public. Accordingly, all Designated Persons and their immediate relatives of the Company are advised not to trade in the securities of the Company during the aforesaid period of Closure of Trading Window. This trading window closure notice operates independently and does not intend to amend, alter, modify, curtail, or extend any other notice(s) on the closure of trading window, if any, for any other purpose, whether currently in effect or to be issued during the validity of this notice.
The above information is a part of company’s filings submitted to BSE.